Skip to main content
. 2020 Oct 22;10:581189. doi: 10.3389/fonc.2020.581189

Table 2.

Best response rate by mRCC histology in patients with evaluable response (n = 21).

Clear cell Non-Clear cell Total
(n = 11) (n = 10) (n = 21)
Papillary Unclassified Translocation
(n = 7*) (n = 2) (n = 1)
ORR 6 (29%) 1 (5%) - - 7 (33%)
CR 1 (5%) 1 (5%) - - 2 (10%)
PR 5 (24%) - - - 5 (24%)
SD 2 (10%) 3 (14%) 1 (5%) - 6 (29%)
PD 3 (14%) 3 (14%) 1 (5%) 1 (5%) 8 (38%)
*

This group includes three patients with clear cell component.